Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2016 (2016), Article ID 8605274, 4 pages
http://dx.doi.org/10.1155/2016/8605274
Case Report

Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still’s Disease

1Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany
2Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany

Received 29 September 2016; Accepted 7 November 2016

Academic Editor: Gregory J. Tsay

Copyright © 2016 Eva Johanna Schäfer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Janka, “Familial and acquired hemophagocytic lymphohistiocytosis,” Annual Review of Medicine, vol. 63, no. 1, pp. 233–246, 2012. View at Publisher · View at Google Scholar
  2. G. S. Schulert and A. A. Grom, “Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies,” Annual Review of Medicine, vol. 66, no. 1, pp. 145–159, 2015. View at Publisher · View at Google Scholar
  3. B. E. Favara, A. C. Feller, M. Pauli et al., “Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society,” Medical and Pediatric Oncology, vol. 29, no. 3, pp. 157–166, 1997. View at Publisher · View at Google Scholar
  4. S. Sawhney, P. Woo, and K. J. Murray, “Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders,” Archives of Disease in Childhood, vol. 85, no. 5, pp. 421–426, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ravelli, F. Minoia, S. Davì et al., “2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis,” Annals of the Rheumatic Diseases, vol. 75, no. 3, pp. 481–489, 2016. View at Publisher · View at Google Scholar
  6. J.-I. Henter, M. Arico, R. M. Egeler et al., “HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis,” Medical and Pediatric Oncology, vol. 28, no. 5, pp. 342–347, 1997. View at Google Scholar · View at Scopus
  7. K. Kaito, M. Kobayashi, T. Katayama et al., “Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases,” European Journal of Haematology, vol. 59, no. 4, pp. 247–253, 1997. View at Google Scholar · View at Scopus
  8. F. Minoia, S. Davì, A. Horne et al., “Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients,” Arthritis and Rheumatology, vol. 66, no. 11, pp. 3160–3169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Dhote, J. Simon, T. Papo et al., “Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review,” Arthritis Care and Research, vol. 49, no. 5, pp. 633–639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Grom, “Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?” Current Opinion in Rheumatology, vol. 15, no. 5, pp. 587–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Rivière, L. Galicier, P. Coppo et al., “Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients,” The American Journal of Medicine, vol. 127, no. 11, pp. 1118–1125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Grom, N. T. Ilowite, V. Pascual et al., “Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab,” Arthritis and Rheumatology, vol. 68, no. 1, pp. 218–228, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Shimizu, Y. Nakagishi, K. Kasai et al., “Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6,” Cytokine, vol. 58, no. 2, pp. 287–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Ravelli, Macrophage Activation Syndrome Differential Diagnoses, 2016, http://emedicine.medscape.com/article/1380671-differential.
  15. E. M. Galińska and J. Zagórski, “Brucellosis in humans—etiology, diagnostics, clinical forms,” Annals of Agricultural and Environmental Medicine, vol. 20, no. 2, pp. 233–238, 2013. View at Google Scholar · View at Scopus
  16. R. M. Traxler, M. W. Lehman, E. A. Bosserman et al., “A literature review of laboratory-acquired brucellosis,” Journal of Clinical Microbiology, vol. 51, no. 9, pp. 3055–3062, 2013. View at Publisher · View at Google Scholar
  17. L. Fardet, L. Galicier, O. Lambotte et al., “Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome,” Arthritis and Rheumatology, vol. 66, no. 9, pp. 2613–2620, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. E. D. Batu, A. Erden, E. Seyhoğlu et al., “Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases,” Scandinavian Journal of Rheumatology, 2016. View at Publisher · View at Google Scholar
  19. D. Chellapandian, R. Das, K. Zelley et al., “Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens,” British Journal of Haematology, vol. 162, no. 3, pp. 376–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Y. Shaw and M. Schivo, “Weathering a cytokine storm: a case of EBV-induced hemophagocytic lymphohistiocytosis,” Journal of Investigative Medicine High Impact Case Reports, vol. 4, no. 2, 2016. View at Publisher · View at Google Scholar
  21. A. Rudinskaya, M. Shao, and R. G. Lahita, “A young male with more than lupus,” Lupus, vol. 25, no. 13, pp. 1491–1496, 2016. View at Publisher · View at Google Scholar